Verlinvest leads €24.5m investment in Liva Healthcare

The firm is the family office of the founding family of AB InBev, which operates as an evergreen structure. Simon Sallustio, Verlinvest executive director told Unquote the firm is very flexible with equity tickets, which can range from very small amounts up to more than €100m. Verlinvest currently has 26 investments, mainly in private companies.

The company's other existing investors also participated in the round; they include Digital Health Ventures, MIG and Santo Venture Capital.

The round will be completed in two tranches and is expected to be followed by a series-C in 2022, according to a statement. Sallustio will take a place on the company's board, following this transaction.

Previous funding
The company raised $212,100 in 2016 and another $3.8m in 2017 from undisclosed investors.

Digital Health Ventures, MIG and Santo Venture Capital invested in a $9m funding round for the company in 2019.

Company
Liva is a health technology company headquartered in Copenhagen and London that aims to improve the lives of people at risk of, or living with, chronic conditions such as Type 2 diabetes, obesity, and heart diseases. Liva was founded in 2015 and employs 40-50 people.

People
Verlinvest – Simone Sallustio (executive director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Nordics
• Technology
• Healthcare
• United Kingdom
• Denmark
• Family Offices